Editorial
Low tidal volume ventilation in acute respiratory distress syndrome Ashwini Jahagirdar, Shirish Prayag Ashbaug first described acute respiratory distress syn drome (ARDS) in 1967 [1] in patients having acute respi ratory distress, cyanosis refractory to oxygen therapy, decreased lung compliance, and diffuse infiltrates evi dent on the chest radiograph. The definitions have evolved since then to the recent most accepted one pro posed by the American-European Consensus Confer ence Committee. [2] . The definition has an advantage: it recognizes that the severity of the clinical lung injury varies; the patients with less severe hypoxemia with the ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen (PaO 2 /FiO 2 ) less than or equal to 300 are considered to have acute lung injury (ALI) and those with more severe hypoxemia with PaO 2 /FiO 2 less than or equal to 200 are considered to have ARDS.
The syndrome has been frustratingly resistant to treat ment and the mortality from ARDS still remains very high. Years of clinical research have led to conceptual clarifi cation of the etiopathogenesis of the lung injury in ALI/ ARDS. Studies in experimental models strongly suggest that the traditional mechanical ventilation approaches could actually cause ventilator-induced lung injury. [3, 4] Besides this, the lung injury which was believed to be diffuse and homogenous on the chest radiographs is actually patchy. [5] . There is, hence, a preferential distri bution of large tidal volumes and higher inspiratory pres sures to the normal alveoli, causing overdistension and stretch injury. In addition, the repeated cyclic opening and closing of alveoli during mechanical ventilation sub jected the lung to shear injury.
Characteristic pressure-volume curves have described the mechanics of lung injury in ALI/ARDS. [6] In the sig moid-shaped pressure-volume curve, ventilatory pres sures higher than the upper inflection point cause overdistension and stretch. Lowering the end-expiratory pressures below the lower inflection point causes re peated collapse and reopening causing shear injury.
Clinical trials and research have ushered in the hope of improving survival rates by newer protective lung strat egies aimed at preventing the stretch and shear injury. Interestingly, a recent study even found that a strategy of protective ventilation could reduce both the pulmo nary and systemic cytokine response. [7] The protective lung strategies essentially recommend a gentler venti lation using lower tidal volumes, limiting the inspiratory and plateau pressures, and in that process accept per missive levels of hypercapnia. With this ventilation strat egy, protection of lungs from excessive stretch is given higher priority than the attainment of normal partial pres sure of arterial carbon dioxide (pCO 2 ) and pH with the traditional approach.
In 1990, Hickling et al. [8] reported clinical experiences in severe ARDS patients using low tidal volumes and pressure-limited ventilation with permissive hypercap nia aimed at reducing ventilator-associated lung injury. The mortality was found to be lower in the study group in this retrospective study. [8] Free full text available from www.ijccm.org This concept was exciting and led to further clinical trials conducted to replicate the benefits of low tidal vol umes, [9] [10] [11] [12] [13] with conflicting results.
Stewart and co-workers, in 1998, randomized patients at a high risk of ARDS within 24 h of intubation [9] into a control group that received conventional ventilation with mean tidal volumes of 10.8 ml/kg body weight and a peak inspiratory pressure limit of 50 cm H 2 O. The study group received protective ventilation with a mean tidal volume of 7.2 ml/kg of body weight and a peak inspira tory limit of 30 cm H 2 O. No difference in mortality was found in the two groups. In fact, the morbidity in the study group was higher with more patients needing dialysis for renal failure. The plateau pressure in the control group was 28.8 cm H 2 O, which was significantly below the limit of 35 cm H 2 O, associated with lung injury. It was hence concluded that mechanical ventilation limiting tidal vol umes and inspiratory pressures is unlikely to be benefi cial and is not warranted for routine use in such patients. This conclusion was also supported by similar findings in two trials conducted by Brower et al. [10] and Brochard et al. [11] The trial conducted by Amato and co-workers on 53 patients revealed strikingly different findings. [12] The study was designed to limit lung injury from overdistending volumes and high inspiratory pressures and maintain ing a level of positive-end expiratory pressure (PEEP) that prevented the majority of alveoli from collapsing at end exhalation. PEEP in the protective ventilation group was set just above the lower inflection point of the pres sure volume curve. Tidal volumes and inspiratory pres sures were also substantially reduced. The protective ventilation approach was associated with significant im provements in 28-day survival rates, rates of weaning, and frequency of barotrauma.
A large multicentre randomized trial was conducted by the ARDS Network to study the effects of lower tidal volumes in ventilating patients with ALI and ARDS. [13] The trial compared traditional ventilation (initial tidal vol ume of 12 ml/kg of predicted body weight and a plateau pressure of 50 cm H 2 O or less) vs ventilation with lower tidal volume (initial tidal volume of 6 ml/kg of predicted body weight and a plateau pressure of 30 cm H 2 O or less).
The first primary outcome was death before a patient was discharged home and was breathing without as sistance. The second primary outcome was the number of days without ventilator use from day 1 to day 28.
The trial was stopped after the enrollment of 861 pa tients because mortality was lower in the group treated with lower tidal volumes (31% vs 39%) and the days without ventilator use during the first 28 days after randomizaton was greater in this group. The mean tidal volumes were 6.2 ± 0.8 and 11 ± 0.8 ml/kg of predicted body weight, and the plateau pressures were 25 ± 6 and 33 ± 8 cm H 2 O, respectively. Thus, mortality was reduced by 22% and the number of ventilator-free days was greater in the group treated with lower tidal volumes than in the group treated with traditional tidal volumes.
These benefits were observed despite the higher re quirements for PEEP and FiO 2 and the lower PaO 2 /FiO 2 in the group treated with lower tidal volumes. These were coupled with greater reductions in the concentrations of plasma interleukin 6 in the group reflecting a reduced systemic inflammatory response to lung injury. The lower output of inflammatory mediators could contribute to the higher number of days without organ system failure and the lower mortality in the group treated with lower tidal volumes. [14] Following the conclusions made by the ARDS Network Trial, important issues were raised regarding the cred ibility and the interpretation of these landmark clinical trials [12, 13] of patients with ARDS.
Eichacker pointed out that the trials showing low tidal volumes to be beneficial did not use control arms that reflected the current best practice standards at the time. [15] Instead, the trials compared very low tidal vol umes (5-7 ml/kg of measured body weight) with tradi tional tidal volumes (10 ml/kg or more), which were higher than those routinely used. [16] [17] [18] [19] A meta-analysis of the two beneficial trials [12, 13] and the nonbeneficial trials [9] [10] [11] suggests that there were important postrandomization differences in airway pressures in the control arms of the five trials. [15] The three nonbeneficial trials used con trol tidal volumes that resulted in lower airway pressures (28-32 cm H 2 O), consistent with routine care at the time of the studies. [17] Compared with these controls, low tidal volumes did not improve outcomes. However, the two beneficial trials compared low tidal volume ventilation with control arms with airway pressures high enough (34-37 cm H 2 O) to potentially increase control mortality rates. In this setting, low tidal volumes may mistakenly appear beneficial. This concern of unconventionally high pla teau pressures in the group treated with traditional vol umes that may account for the different outcomes in the ARDS Network Trial was also voiced by others. [20] The meta-analysis failed to prove the superiority of the low tidal volumes over the current traditional practice method. However, it clearly indicated that using very high tidal volumes associated with high plateau pressures (>34 cm H 2 O) was harmful and should be avoided. [15] Besides, the nonbeneficial trials used control arms that closely reflected the practice of the physicians treating ALI/ARDS. [17] [18] [19] These trials established that as long as tidal volumes produce airway pressures between 28 and 32 cm H 2 O there is no benefit in using low tidal volumes. The ARDS Network Trial protocol not only specified a "traditional" high tidal volume for control subjects (rather than current practice in the study centers), but also re stricted the physician's ability to adjust tidal volumes unless airway pressures were very high (more than 50 cm H 2 O). Moreover, this study design may have resulted in inferior treatment conferred on the patients in the con trol arm of the study.
As a result, the meta-analysis concluded that neither of the two beneficial trials can determine whether rais ing tidal volumes and airway pressure worsened out comes or lowering tidal volumes and airway pressures improved them compared with the practice that was cur rent among participating physicians at the study centers. Further, even if low tidal volumes are beneficial and im prove clinically important outcomes, this study might have overestimated the effects of low tidal volumes be cause of the unusually high tidal volumes and high pla teau pressures used in the group treated with traditional tidal volumes. [15] In spite of the fact that the meta-analysis did not show any benefits of using lower tidal volumes for ALI/ARDS patients, it had its own limitations and pitfalls. The lack of standard control in the studies relevant to the prevail ing practice at the time as pointed in the meta-analysis is largely based on an international survey of ventilation practices conducted by Carmichael and co-workers. [16] Variability in the reported practice was profound and a wide disparity existed in the selection of tidal volumes. Over half of the respondents in the survey reported us ing tidal volumes that were high or higher than those received by the traditional group. Also, the use of pla teau pressures that influenced the adjustment of tidal volumes was not systematic. Two general approaches seemed to be prevalent at the time as per differing clini cal priorities. One approach used generous tidal volumes with high plateau pressures in order to maintain gas ex change and breathing comfort. [21, 22] The other approach [8] used lower tidal volumes and inspiratory pressures to prevent overdistension and lung injury as per experimen tal evidence. [4] The disparity in physician-selected tidal volumes and the absence of a clear plateau pressure limit indicate the lack of any prevailing standard practice at the time which could have any relevance to the re sults of the trials, thus refuting any claims made by Eichacker and co-workers. [15] There were views [23] that in addition to the low tidal volumes and plateau pressures, other factors also may have played an important part in improving the outcomes of the ARDS Network Trial. The significantly higher PEEP used in the study group with low tidal volumes provided the lung recruitment and was actually protective and necessary for lung protection when tidal volumes were reduced. [12] The nonstandardized partial buffering of hy percapnic acidosis associated with low tidal volumes also seemed to affect the outcomes; given the evidence that academia, in general, [24] and hypercapnic acidosis may have beneficial effects. [25] Another possible explanation given for the lower mortality rates with lower tidal vol umes is improved systemic oxygen delivery. Reduced inspiratory airway pressures in patients receiving low tidal volumes may increase cardiac output and diminish the need for exogenous vasopressor drugs. Decreased use of these drugs would improve microvascular organ perfusion. [26] Additionally, as observed by Brower and co-work ers, [27] the three nonbeneficial studies were too small to provide convincing evidence for the lack of efficacy. Even if these studies were combined, the difference between the higher and lower tidal volume groups was not statistically significant. [27] A recent trial [28] has given additional weight to the ARDS network study. Similar to the ARDS network trial, Kallet and co-workers conclude that despite the heterogeneity of underlying lung injury typically present in this patient population, their findings strongly suggest that the low tidal volume strategy may benefit all patients with ALI or ARDS.. [28] Other leaders in the field believe that tidal volumes in patients with ALI and ARDS should be ti trated based on surrogate markers of lung injury, such as airway pressures or lung strain. [29] [30] [31] [32] These physicians indicate that although some patients, such as those with poor pulmonary compliance and high airway pressures, would benefit from very low tidal volume, others with less severe lung injury may require larger volumes to maintain ventilation and avoid alveolar collapse.
In a recent major study on outcome of patients with ALI/ARDS, a multivariable logistic regression analysis showed that the independent risks for mortality included, use of tidal volumes higher than those used by the ARDS net study. [33] Some investigators have used a meta-analysis of all low vs high tidal volume ARDS trials to argue that P PLAT alone would be an adequate target, independent of V T , and 6 ml/kg V T could be problematic in patients who had already achieved an inspiratory plateau pressure target of 28-32 cm H 2 O. [15] Those who counter that argument point to an analysis of the effect of low vs high tidal vol umes across the four quartiles of P PLAT levels in the ARDS net low V T trial, demonstrating a beneficial effect of 6 ml/kg V T in all four quartiles of P PLAT .
[34] In addition, a beneficial effect of lower tidal excursion independent of P PLAT could be important.
Thus, after what was termed the culmination in an era of research , several questions arise. How do the results of the ARDS Network Trial affect the routine ventilator care of patients with ARDS? Has the trial established a new standard of care for mechanical ventilation of pa tients with ARDS? If not, can clinicians justify the failure to apply what some would consider as evidence-based medicine? [32] An alternative approach to mechanical ventilation that has generated a great deal of interest over the past dec ade is high-frequency ventilation (HFV). Broadly speak ing, HFV is defined as mechanical ventilatory support using higher than normal frequencies generally >100 breaths/min in adult and >300 breaths/min in pediatric population. When these frequencies are used, tidal vol umes are much smaller than normal, may be less than the anatomic dead space and airway pressure swings are consequently less. The smaller tidal pressure swings coupled with appropriate baseline pressure elevations, create a conceptually ideal " lung protective strategy." Specifically, the combination of applied and intrinsic PEEP provides alveolar recruitment and the smaller tidal pressure swings prevent overdistension. The rapid flow pattern in HFV may enhance gas exchange and improve ventilation-perfusion matching.
Adult experience with HFV has been limited and lit erature does not show improvement in outcome.
[35] Thus, more clinical data should be available to make it appli cable as standard care for ARDS. The interesting per spective of HFV here is that perhaps the efficacy of HFV will throw more light on how much tidal volume is desir able and how low can we go.
Conclusion
Since the time that ARDS/ALI was first understood as an entity by Ashbaug, [1] considerable progress has been made in understanding the pathogenesis. Extensive re search has been carried out to characterize subgroup of patients, identify patients at high risk early in the course of their illness, delineate the biology and mechanics of alveolar damage, and define molecular markers and mediators. However, strategies for betterment of out comes have more or less remained a matter of debate. More than 30 years of research in formulating new thera pies in the form of ways to improve oxygen delivery, nitric oxide, glucocorticoids, prostacyclins, etc., have yet to yield tangible results.
The five clinical trials [9] [10] [11] [12] [13] provide a platform for devel opment of better strategies for mechanical ventilation in ARDS. Notwithstanding the debatable issues revolving around the trials, the ARDS Network Trial is the culmi nation of a series of mechanistic physiologic studies that have elucidated the new principle. [36] There are lessons to be learnt from this breakthrough trial [13] that provide a new strategy for healing injured lungs. The goal of ventilatory strategy henceforth should be to minimize lung injury by reducing the tidal volumes and keeping the plateau pressures below 32 cm H 2 O and provide a gentler ventilation.
[36]
Despite extensive discussions and debates on this strategy, we have examples of both low and high rates of compliance with the use of low tidal volumes for pa tients with ALI. [28, 37] Until another ventilatory strategy proves clear survival benefits for patients of ARDS, low tidal volumes (6-8 ml/kg of predicted body weight) should be regarded as a standard approach to ventilating patients of ARDS.
